Pancreatic cancer is one of the most lethal malignancies. With the promising prospects
conveyed by immunotherapy in cancers, we aimed to construct an immune‐related gene …

Background. Pancreatic cancer patients with similar clinicopathological status exhibit
substantially different therapeutic responses, which might be caused by the vast molecular …

Background Pancreatic cancer is one of the most common malignant tumors of the digestive
tract, and it has a poor prognosis. Traditional methods are not effective to accurately assess …

Increasingly attention is being given to immune molecules in pancreatic cancer. The
purpose of this study was to understand the potential clinical application of immune …

Pancreatic cancer remains to have a high mortality, which is partly due to the lack of effective
treatment strategies. In this study, genes with potential associations with …

Objective Our goal is to construct an immune-related gene prognostic risk index (IRGPRI) for
pancreatic adenocarcinoma (PAAD), and to clarify the immune and molecular features in …

Abstract Background Immune-related genes (IRGs) are associated with the prognosis of
different cancers and are helpful for the diagnosis and management of systematic treatment …

Background The immune response in the tumor microenvironment (TME) plays a crucial role
in cancer progression and recurrence. We aimed to develop an immune-related gene (IRG) …

Pancreatic adenocarcinoma (PAAD) has high mortality and a very poor prognosis. Both
surgery and chemotherapy have a suboptimal therapeutic effect, and this caused a need to …

Background. The prognosis of pancreatic adenocarcinoma (PAAD) is extremely poor and
has not been improved. Thus, an effective method to assess the prognosis of patients must …